University of Michigan researchers have uncovered a potential driver behind one of the most common pediatric brain tumors. The study reveals how a specific molecule interacts with a cancer-linked protein in ways that may shape tumor growth. With clinical trial development underway, the findings could influence how these tumors are treated. Read more about the science behind this emerging approach.
